糖尿病新世界
糖尿病新世界
당뇨병신세계
DIABETES NEW WORLD
2015年
8期
55-56
,共2页
2型糖尿病%消渴丸%二线用药
2型糖尿病%消渴汍%二線用藥
2형당뇨병%소갈환%이선용약
Type 2 Diabetes%DiabetesPill%Second-line drug
目的：观察消渴丸联合二甲双胍治疗2型糖尿患者的临床疗效。方法将78例患者随机分为研究组与对照组各39例，两组均采用饮食、生活方式干预及原二甲双胍治疗。在此基础上，研究组予合并口服消渴丸治疗，对照组予合并口服标准药物格列本脲片，两组治疗前后均查空腹血糖、餐后2h血糖、糖化血红蛋白，探讨消渴丸联合二甲双胍治疗2型糖尿病患者的临床疗效。结果研究组空腹血糖、餐后2h血糖、糖化血红蛋白均有显著下降，对照组仅空腹血糖、餐后2 h血糖有显著下降，但两组间的改善比较差异没有显著性。治疗后研究组达标率(糖化血红蛋白＞7.0%)51.3%；对照组达标率41.0%，研究组高于对照组，但两组间的改善比较差异没有显著性。结论消渴丸作为二线药物联合二甲双胍疗效可靠，值得临床推广应用。
目的：觀察消渴汍聯閤二甲雙胍治療2型糖尿患者的臨床療效。方法將78例患者隨機分為研究組與對照組各39例，兩組均採用飲食、生活方式榦預及原二甲雙胍治療。在此基礎上，研究組予閤併口服消渴汍治療，對照組予閤併口服標準藥物格列本脲片，兩組治療前後均查空腹血糖、餐後2h血糖、糖化血紅蛋白，探討消渴汍聯閤二甲雙胍治療2型糖尿病患者的臨床療效。結果研究組空腹血糖、餐後2h血糖、糖化血紅蛋白均有顯著下降，對照組僅空腹血糖、餐後2 h血糖有顯著下降，但兩組間的改善比較差異沒有顯著性。治療後研究組達標率(糖化血紅蛋白＞7.0%)51.3%；對照組達標率41.0%，研究組高于對照組，但兩組間的改善比較差異沒有顯著性。結論消渴汍作為二線藥物聯閤二甲雙胍療效可靠，值得臨床推廣應用。
목적：관찰소갈환연합이갑쌍고치료2형당뇨환자적림상료효。방법장78례환자수궤분위연구조여대조조각39례，량조균채용음식、생활방식간예급원이갑쌍고치료。재차기출상，연구조여합병구복소갈환치료，대조조여합병구복표준약물격렬본뇨편，량조치료전후균사공복혈당、찬후2h혈당、당화혈홍단백，탐토소갈환연합이갑쌍고치료2형당뇨병환자적림상료효。결과연구조공복혈당、찬후2h혈당、당화혈홍단백균유현저하강，대조조부공복혈당、찬후2 h혈당유현저하강，단량조간적개선비교차이몰유현저성。치료후연구조체표솔(당화혈홍단백＞7.0%)51.3%；대조조체표솔41.0%，연구조고우대조조，단량조간적개선비교차이몰유현저성。결론소갈환작위이선약물연합이갑쌍고료효가고，치득림상추엄응용。
objective To observe the clinical curative effect of Xiaoke pill combined with metformin in the treatment of patients with type 2 diabetes.Methods 78 patients were randomly divided into study group and control group with 39 cases in each group, two groups use the diet, lifestyle intervention and metformin in the treatment of primary.On this basis, combined group was treated with Xiaoke pill treatment, control group was given combination oral drug standard Glibenclamide Tablets, before and after treatment in two groups were fasting blood glucose, postprandial 2H blood glucose, glycated hemoglobin, to discuss the therapeutic effect of Xiaoke pill combined with metformin in patients with type 2 diabetes mellitus.Results Research group of fasting blood glucose, 2h postprandial blood glucose, glycosylated hemoglobin decreased significantly, the control group only fasting blood glucose, postprandial 2H blood glucose was significantly decreased, but the two groups did not differ significantly improved comparison. After the treatment, study group compliance rate (HbHAIc>7%) in 51.3%;the control group compliance rate of 41%, the study group was higher than control group, but between the two groups did not differ significantly improved comparison.Conclusion Effect of Xiaoke pill combined with metformin as second-line drugs, reliable, worthy of clinical application.
